Diabetes outcomes in people with severe mental illness

Affiliations

¹ Institute for General, Family and Preventive Medicine, Paracelsus Medical Private University, Salzburg, Austria.
² King's College London, London.
³ Clinical Advisor to the National Diabetes Audit. St John's Medical Centre, Walsall.
⁴ Institute of Psychiatry, Psychology and Neurosciences, King's College London, London.

Editorial

Alan Cohen et al. Br J Gen Pract. 2018 Apr.

. 2018 Apr;68(669):166-167.

doi: 10.3399/bjgp18X695381.

¹ Institute for General, Family and Preventive Medicine, Paracelsus Medical Private University, Salzburg, Austria.
² King's College London, London.
³ Clinical Advisor to the National Diabetes Audit. St John's Medical Centre, Walsall.
⁴ Institute of Psychiatry, Psychology and Neurosciences, King's College London, London.

No abstract available

References

1. NHS Digital . National Diabetes Audit, 2017–2018. [In press]
1. Ashworth M, Schofield P, Das-Munshi J. Physical health in severe mental illness. Br J Gen Pract. 2017. DOI: https://doi.org/10.3399/bjgp17X692621. - DOI - PMC - PubMed
1. Vinogradova Y, Coupland C, Hippisley-Cox J, et al. Effects of severe mental illness on survival of people with diabetes. Br J Psychiatry. 2010;197(4):272–277. - PubMed
1. Smith M, Hopkins D, Peveler RC, et al. First-v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2008;192(6):406–411. - PubMed
1. Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951–962. - PubMed